Pharmacokinetic and Pharmacodynamic Evaluation of Rivaroxaban: Considerations for the Treatment of Venous Thromboembolism

Thrombosis Journal- United Kingdom

doi 10.1186/1477-9560-12-22

Full Text

Abstract

Available in

Categories

Date

January 1, 2014

Authors

Sebastian Harder

Publisher

Springer Science and Business Media LLC

Related search

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Journal of Vascular Surgery: Venous and Lymphatic Disorders

Cardiovascular Medicine

English

Pharmacokinetic and Pharmacodynamic Considerations of Rifamycin Antibiotics for the Treatment of Tuberculosis

Expert Opinion on Drug Metabolism and Toxicology

English

Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis

English

The Cost-Effectiveness of Dabigatran Etexilate Compared With Rivaroxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health

Occupational Health

English

Rivaroxaban Versus Warfarin Treatment Among Morbidly Obese Patients With Venous Thromboembolism: Comparative Effectiveness, Safety, and Costs

Thrombosis Research

English

Long-Term Rivaroxaban for the Treatment of Acute Venous Thromboembolism in Patients With Active Cancer in a Prospective Multicenter Trial

Korean Journal of Internal Medicine

Internal Medicine

English

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Journal of Vascular Surgery

Cardiovascular Medicine

English

Efficacy, Pharmacokinetic and Pharmacodynamic Evaluation of Apaziquone in the Treatment of Non-Muscle Invasive Bladder Cancer

Expert Opinion on Drug Metabolism and Toxicology

English

Evaluation of the Pharmacodynamic and Pharmacokinetic Interaction Between Pagoclone and Ethanol.

Clinical Pharmacology and Therapeutics

English